Gabriela Rodríguez Macias

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis

Alemnew F. Dagnew, Osman İlhan, Won Sik Lee et al. · The Lancet Infectious Diseases · 2019 · 254 citations · Full text

Veterinary Medicine, Immunology, Oncology +16

Effects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: Results from the multicentre, randomised, double-blind, active-controlled HARMONY II study

Gabriela Rodríguez Macias, Gabriele S. Merki‐Feld, Susanne Parke et al. · Journal of Obstetrics and Gynaecology · 2013 · 42 citations

Medicine, Pharmacology, Pharmacotherapy +17

Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group

Tomás Palanques-Pastor, Juan Eduardo Megías‐Vericat, Pilar Martı́nez et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2021 · 33 citations · Full text

Medicine, Infectious Diseases, Pharmacology +16

AML-484 First Results of a Phase II Study (STIMULUS-AML1) Investigating Sabatolimab + Azacitidine + Venetoclax in Patients With Newly Diagnosed Acute Myeloid Leukemia (ND AML)

Amer M. Zeidan, Jörg Westermann, Tibor Kovacsovics et al. · Clinical Lymphoma Myeloma & Leukemia · 2022 · 17 citations

Medicine, Pharmacology, Pharmacotherapy +12

Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility

Ignacio Gómez‐Centurión, Gillen Oarbeascoa, María Carmen López Fresneña et al. · International Journal of Hematology · 2021 · 16 citations · Full text

Medicine, Hematology, Internal Medicine +8